Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Beta Drugs LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:535022 NSE Symbol: BETA P/E (TTM) :82.38
ISIN Demat:INE351Y01019 Div & Yield %:0 EPS (TTM) :21.73
Book Value (RS) :114.9351178 Market Cap (Rs Cr.):1807.13 Face Value (RS) :10
    Change Company 
YearsMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debt-Equity Ratio0.050.070.090.120.17
Long Term Debt-Equity Ratio0.030.050.060.060.09
Current Ratio2.532.602.472.081.71
Fixed Assets3.162.782.571.882.14
Inventory11.1014.2715.4411.5210.44
Debtors4.204.214.793.813.42
Interest Cover Ratio29.0931.0150.2013.8314.98
PBIDTM (%)17.8420.4220.8620.0418.63
PBITM (%)15.4516.5016.4813.4014.68
PBDTM (%)17.3119.8920.5319.0717.65
CPM (%)13.4915.8415.7915.4214.82
APATM (%)11.1011.9211.418.7810.87
ROCE (%)26.6027.2026.1915.5916.64
RONW (%)20.6721.6720.2311.6514.63

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)